EchoGo Core
Ultromics
|
Information source:
Vendor
Last updated: January 22, 2022 |
General Information
| General | |
|---|---|
| Product name | EchoGo Core |
| Company | Ultromics |
| Subspeciality | Cardiac |
| Modality | Ultrasound |
| Disease targeted | Cardiac disease |
| Key-features | Ventricle volume analysis, ejection fraction, strain, worksheet generation |
| Suggested use | During: interactive decision support (shows abnormalities/results only on demand), report suggestion After: diagnosis verification Without interference of a radiologist: AI-only diagnosis |
Technical Specifications
| Data characteristics | |
|---|---|
| Population | All resting echo indications in adults |
| Input | Resting Echo |
| Input format | DICOM |
| Output | PDF Report |
| Output format | |
| Technology | |
| Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
| Deployment | Locally virtualized (virtual machine, docker), Cloud-based |
| Trigger for analysis | Automatically, right after the image acquisition |
| Processing time | 10 - 60 seconds |
Regulatory
| Certification | |
|---|---|
| CE |
Certified,
Class I
, MDD
|
| FDA | 510(k) cleared , Class II |
| Intended Use Statements | |
| Intended use (according to CE) | 5.1. Intended Use Quantification of cardiovascular function from an echocardiogram. 5.2. Indication for Use EchoGo Core is intended to be used for the quantification and reporting of results of cardiovascular function to support physician diagnosis. EchoGo Core is indicated for use in adult populations. |
Market
| Market presence | |
|---|---|
| On market since | 11-2019 |
| Distribution channels | Caption Health |
| Countries present (clinical, non-research use) | 2 |
| Paying clinical customers (institutes) | 1 |
| Research/test users (institutes) | 3 |
| Pricing | |
| Pricing model | Pay-per-use, Subscription |
| Based on | Number of analyses |